Initial Combination of Gemigliptin and Metformin on Microbiota Change
Status:
Completed
Trial end date:
2021-03-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate gut microbiota change and glucose lowering effect
of initial combination therapy of gemigliptin and metformin compared to glimepiride and
metformin in obese patients with type 2 diabetes.